Bio-Rad Laboratories (BIO) 10-Q2012 Q1 Quarterly report

Filed: 10 May 12, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: accumulation, addressed, adjusted, adjustment, agreed, applicable, applied, approval, Bulletin, categorized, Chairman, closing, corrected, correction, curtail, death, depressed, discount, discounted, DNA, dramatically, effort, enhanced, enterprise, error, exposure, fell, forma, Greece, headcount, high, identical, imbalance, incentive, inclusion, incorrectly, isolation, Italy, iv, knowledge, labor, longer, milestone, notional, orderly, overstatement, passed, perspective, portfolio, Portugal, private, pro, project, projected, pull, raw, reagent, reconciliation, reimbursement, renegotiating, rental, reorganization, resolved, Resource, SAB, sector, Singapore, situation, sovereign, statistical, stipulated, study, supplemental, sustained, tangible, tolerable, tolling, understatement

Removed: accomplishing, alerting, alike, alternative, Analitica, attempt, August, benchmark, Biotest, brokered, building, challenging, characteristic, collateralized, conclusion, consistency, correlation, de, deposit, detect, developing, devote, DiaMed, Distribuidora, equity, escrow, examine, extension, final, flat, frequency, group, hand, identifying, immunohematology, implementing, improved, inactive, increasing, inherent, initiate, initiated, initiation, institutional, insufficient, issuance, issuer, maintenance, Medicina, mentioned, microbiology, monthly, mortgage, Nationally, NRMSIR, para, performing, person, prevent, professional, quantified, received, recession, redeemed, reduced, reference, reliability, remediation, Repository, reputation, retire, set, settlement, showing, spread, submit, tighter, timing, tranche, type, vintage, widening

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

BIO similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

Certification of Periodic Report

I, Norman Schwartz, Chief Executive Officer of Bio-Rad Laboratories, Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:


(1)	the Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2012 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m); and


(2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Date:	May 10, 2012	/s/ Norman Schwartz
		Norman Schwartz
		Chief Executive Officer